Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 71Recruiting 45Terminated 17Unknown 16Not yet recruiting 11Active not recruiting 9Withdrawn 5Suspended 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neoplasms 35Breast Neoplasms 30Prostatic Neoplasms 21Colorectal Neoplasms 21Leukemia, Myeloid, Acute 19Pancreatic Neoplasms 17Melanoma 17Glioblastoma 16Carcinoma, Non-Small-Cell Lung 16Neoplasm Metastasis 15Lung Neoplasms 13Brain Neoplasms 13Glioma 12Carcinoma, Hepatocellular 12Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Ovarian Neoplasms 9Multiple Myeloma 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma 8Carcinoma, Renal Cell 8Rectal Neoplasms 6Leukemia 6Hematologic Neoplasms 6Esophageal Neoplasms 6Uterine Cervical Neoplasms 5Sarcoma 5Recurrence 5

Interventions

lutetium Lu 177 dotatate 1Surveys and Questionnaires 1Sunitinib 1Magnetic Resonance Imaging 1Hydroxyurea 1Fertility 1Everolimus 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Interventional × Meningioma × Clear all
NCT06955169 2026-05-22

MOMENTUM-1

RTOG Foundation, Inc.

Phase 2 Suspended
153 enrolled
CNS

Meningioma

NCT07353229 2026-01-23

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Thomas Jefferson University

Phase 1 Suspended
24 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡